Droloxifene

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDroloxifene
Drug Alias Namedroloxifenum屈洛昔芬droloxifenoDroloxifene citrateK-060 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors modulators
TargetsEstrogen receptors
Therapy Area/IndicationsAtherosclerosisOsteoporosis, PostmenopausalOsteoporosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsAtherosclerosisOsteoporosis, PostmenopausalOsteoporosis +[4] 

Other Information

ATC CodeN/A
Related LinksKEGG